Diabetes, Vol 46, Issue 8 1247-1256, Copyright © 1997 by American Diabetes Association

ARTICLES

Scientific and political impediments to successful islet transplantation

GC Weir and S Bonner-Weir
Research Division, Joslin Diabetes Center, Boston, MA 02215, USA. weirg@joslab.harvard.edu

Islet transplantation is a treatment for diabetes that has the potential to normalize glucose levels and prevent the development of complications. In spite of the simplicity of the concept and the urgent need to provide such a treatment to patients, there has been a frustrating lack of progress. This perspective delves into the scientific and political impediments to success. The scientific barriers are the need to find a satisfactory source of insulin-producing tissue and the requirement to prevent this tissue from being destroyed by immune rejection and autoimmunity. The problems and potential of allografts, xenografts, and the development of cell lines are discussed. Multiple approaches to the prevention of immune destruction are considered, including immunobarrier devices, immunosuppression, development of tolerance, and genetic manipulation. The political barriers discussed include the problems of high expectations, the controversy surrounding targeted research, the balance between basic and applied research, the roles of industry and academia, the concerns about xenotransplantation, and the difficulties in developing a planned approach to the problem.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Liuwantara, M. Elliot, M. W. Smith, A. O. Yam, S. N. Walters, E. Marino, A. McShea, and S. T. Grey Nuclear Factor-{kappa}B Regulates {beta}-Cell Death: A Critical Role for A20 in {beta}-Cell Protection Diabetes, September 1, 2006; 55(9): 2491 - 2501. [Abstract] [Full Text] [PDF]

				Y. H. Choi, J. H. Lee, S. H. Yuk, S. H. Suh, and K.-H. Yoon Core/Shell Macrobeads for the Protection of Islets from Immune System Rejection Journal of Bioactive and Compatible Polymers, January 1, 2006; 21(1): 71 - 81. [Abstract] [PDF]

				S. Yoshida, F. Ishikawa, N. Kawano, K. Shimoda, S. Nagafuchi, S. Shimoda, M. Yasukawa, T. Kanemaru, H. Ishibashi, L. D. Shultz, et al. Human Cord Blood-Derived Cells Generate Insulin-Producing Cells In Vivo Stem Cells, September 1, 2005; 23(9): 1409 - 1416. [Abstract] [Full Text] [PDF]

				H. Kaneto, T.-a. Matsuoka, Y. Nakatani, T. Miyatsuka, M. Matsuhisa, M. Hori, and Y. Yamasaki A Crucial Role of MafA as a Novel Therapeutic Target for Diabetes J. Biol. Chem., April 15, 2005; 280(15): 15047 - 15052. [Abstract] [Full Text] [PDF]

				H. Kaneto, Y. Nakatani, T. Miyatsuka, T.-a. Matsuoka, M. Matsuhisa, M. Hori, and Y. Yamasaki PDX-1/VP16 Fusion Protein, Together With NeuroD or Ngn3, Markedly Induces Insulin Gene Transcription and Ameliorates Glucose Tolerance Diabetes, April 1, 2005; 54(4): 1009 - 1022. [Abstract] [Full Text] [PDF]

				J. L. Contreras, C. Eckstein, C. A. Smyth, G. Bilbao, M. Vilatoba, S. E. Ringland, C. Young, J. A. Thompson, J. A. Fernandez, J. H. Griffin, et al. Activated Protein C Preserves Functional Islet Mass After Intraportal Transplantation: A Novel Link Between Endothelial Cell Activation, Thrombosis, Inflammation, and Islet Cell Death Diabetes, November 1, 2004; 53(11): 2804 - 2814. [Abstract] [Full Text] [PDF]

				H. Segev, B. Fishman, A. Ziskind, M. Shulman, and J. Itskovitz-Eldor Differentiation of Human Embryonic Stem Cells into Insulin-Producing Clusters Stem Cells, May 1, 2004; 22(3): 265 - 274. [Abstract] [Full Text] [PDF]

				A. Omer, V. F. Duvivier-Kali, N. Trivedi, K. Wilmot, S. Bonner-Weir, and G. C. Weir Survival and Maturation of Microencapsulated Porcine Neonatal Pancreatic Cell Clusters Transplanted into Immunocompetent Diabetic Mice Diabetes, January 1, 2003; 52(1): 69 - 75. [Abstract] [Full Text] [PDF]

				N. Trivedi, J. Hollister-Lock, M. D. Lopez-Avalos, J. J. O’Neil, M. Keegan, S. Bonner-Weir, and G. C. Weir Increase in {beta}-Cell Mass in Transplanted Porcine Neonatal Pancreatic Cell Clusters Is Due to Proliferation of {beta}-Cells and Differentiation of Duct Cells Endocrinology, May 1, 2001; 142(5): 2115 - 2122. [Abstract] [Full Text]

				P.-O. Carlsson, F. Palm, A. Andersson, and P. Liss Markedly Decreased Oxygen Tension in Transplanted Rat Pancreatic Islets Irrespective of the Implantation Site Diabetes, March 1, 2001; 50(3): 489 - 495. [Abstract] [Full Text]

				C. D. Ching, R. C. Harland, B. H. Collins, W. Kendall, H. Hobbs, and E. C. Opara A Reliable Method for Isolation of Viable Porcine Islet Cells Arch Surg, March 1, 2001; 136(3): 276 - 279. [Abstract] [Full Text] [PDF]

				S. Bonner-Weir, M. Taneja, G. C. Weir, K. Tatarkiewicz, K.-H. Song, A. Sharma, and J. J. O'Neil In vitro cultivation of human islets from expanded ductal tissue PNAS, July 5, 2000; 97(14): 7999 - 8004. [Abstract] [Full Text] [PDF]

				J. F. Markuns, R. Napoli, M. F. Hirshman, A. M. Davalli, B. Cheatham, and L. J. Goodyear Effects of Streptozocin-Induced Diabetes and Islet Cell Transplantation on Insulin Signaling in Rat Skeletal Muscle Endocrinology, January 1, 1999; 140(1): 106 - 111. [Abstract] [Full Text]